药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Arbutamine
Chlorphentermine
The risk or severity of serotonin syndrome can be increased when Chlorphentermine is combined with Flibanserin.
Arbutamine
2,5-Dimethoxy-4-ethylamphetamine
The risk or severity of serotonin syndrome can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Flibanserin.
Arbutamine
Bezitramide
The risk or severity of serotonin syndrome can be increased when Bezitramide is combined with Flibanserin.
Arbutamine
Mephentermine
The risk or severity of serotonin syndrome can be increased when Mephentermine is combined with Flibanserin.
Arbutamine
Dexfenfluramine
The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Flibanserin.
Arbutamine
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Flibanserin.
Arbutamine
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Flibanserin.
Arbutamine
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Flibanserin.
Arbutamine
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Flibanserin.
Arbutamine
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Flibanserin.
Arbutamine
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Flibanserin.
Arbutamine
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Flibanserin.
Arbutamine
GW842166
The risk or severity of adverse effects can be increased when GW842166 is combined with Flibanserin.
Arbutamine
Cannabidiol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Flibanserin.
Arbutamine
Taranabant
The risk or severity of adverse effects can be increased when Taranabant is combined with Flibanserin.
Arbutamine
Rimonabant
The risk or severity of adverse effects can be increased when Rimonabant is combined with Flibanserin.
Arbutamine
SLV319
The risk or severity of adverse effects can be increased when SLV319 is combined with Flibanserin.
Arbutamine
Metreleptin
The metabolism of Flibanserin can be increased when combined with Metreleptin.
Arbutamine
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Flibanserin.
Arbutamine
Regorafenib
The serum concentration of Regorafenib can be increased when it is combined with Flibanserin.